A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

A dopamenu is a personalized list of small, rewarding activities designed to boost focus, motivation and well-being. Here are ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

In the first clinical trial of its kind, people taking semaglutide drank less alcohol, adding to its promise of fighting addiction.

Researcher in molecular biophysics, epigenetics and nutrition, CNRS UMR 7196, Inserm U1154, National Museum of Natural ...

One in six deaths from cardiovascular disease in the United States is due to stroke, and over 100 million people worldwide ...

A recent study by scientists at Massachusetts General Hospital takes a closer look at this debate. Their research suggests ...